Progress in clinical and biological research

publication venue for

Immunological abnormalities in myelofibrosis. 1984
3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.. 385. 1994
Peripheral blood mononuclear mobilization with sargramostim (GM-CSF).. 389. 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.. 385. 1994
New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.. 377. 1992
Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.. 377. 1992
The AIS CELLector: a new technology for stem cell purification.. 377. 1992
131I-3F8: clinical validation of imaging studies and therapeutic applications.. 366. 1991
Differential penetration of targeting agents into multicellular spheroids derived from human neuroblastoma.. 366. 1991
Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.. 366. 1991
Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.. 366. 1991
Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.. 366. 1991
The Studer ileal neo-bladder: anatomical and functional characteristics.. 370. 1991
Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.. 366. 1991
Characterization of human hematopoietic stem cells.. 352. 1990
Immunoregulatory effects of alcohol on lymphocyte responses to human immunodeficiency virus proteins.. 325. 1990
In vitro fertilization and embryo transfer: an established and successful therapy for endometriosis.. 323. 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.. 353. 1990
On the validation of the system of Aspergillus for testing environmental aneugens.. 340B. 1990
Photoradiation methods for purging autologous bone marrow grafts.. 333. 1990
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.. 333. 1990
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.. 353. 1990
Tyrosine hydroxylase and enkephalin in nuclei of the solitary tracts: co-existence and convergent synaptic input to catecholamine neurons.. 328. 1990
Tyrosine hydroxylase and enkephalin in the rostral ventrolateral medulla: major synaptic contacts from opioid terminals on catecholaminergic neurons.. 328. 1990
Vascular uptake of 111-In-platelets and of 123-I-LDL.. 355. 1990
A molecular theoretical model of recognition and activation at a 5-HT receptor.. 289. 1989
A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.. 288. 1989
Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.. 310. 1989
Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21).. 297. 1989
Is chemotherapy a new form of radical treatment in infiltrating tumor localized to the bladder?. 303. 1989
Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer?. 303. 1989
Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.. 303. 1989
On the mechanisms of induced aneuploidy in Aspergillus nidulans and validation of tests for genomic mutations.. 318. 1989
Regulatory protein action in the neighborhood of chicken globin genes during development.. 316A. 1989
Transplantation of retinal epithelium prevents photoreceptor degeneration in the RCS rat.. 314. 1989
Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside.. 288. 1989
When is a cystectomy necessary in carcinoma in situ?. 303. 1989
Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.. 277. 1988
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.. 271. 1988
Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.. 271. 1988
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.. 260. 1988
Measurements of aiCa, aiNa and membrane potential and patch clamp studies of the effect of changes in aiCa on Na channel activity in renal tubules.. 252. 1988
The advanced cancer patient--a clinical profile.. 278. 1988
Adenosine antagonizes the histamine-induced stimulation of human atrial myocardium: protection by H1-receptor blockade.. 230. 1987
Combined interstitial and external irradiation for prostatic cancer.. 243B. 1987
Effects of adenosine on ventricular tachycardia.. 230. 1987
Interstitial irradiation using I-125 seeds.. 243B. 1987
Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.. 244. 1987
Role of second messengers in regulating the growth-associated S6 protein kinase activity.. 249. 1987
Clinical follow-up.. 221. 1986
Surgical techniques in the management of patients with superficial bladder cancer.. 221. 1986
The regulation of collagen type IV(alpha 1) and other genes during the retinoic acid induced differentiation of wild type and mutant mouse teratocarcinoma stem cells.. 226. 1986
A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.. 193. 1985
Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage.. 175. 1985
Chiral analysis of urinary 5-hydroxymethtryptoline: implications for endogenous biosynthesis and formation during ethanol intoxication.. 183. 1985
Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.. 175. 1985
Regulatory role of calcium in sodium transport.. 164. 1984
Role of Ca++ as a regulator of Na+ permeability in epithelia.. 168. 1984
The participation of community hospitals in cancer clinical trials: results and impact of the Eastern Cooperative Oncology Group Program.. 120. 1983
Using retroviruses as insertional mutagens to identify cellular oncogenes.. 119. 1983
Extracorporeal modification of plasma and whole blood.. 106. 1982
The signal hypothesis in bacteria.. 91. 1982
Tryptolines: artifact or reality? A new method of analysis using GC/MS.. 90. 1982
Some structure activity relationships of phencyclidine derivatives as anticholinergic agents in vitro and in vivo.. 27. 1979
Utah pedigree studies: design and preliminary data for premature male CHD deaths.. 32. 1979
HLA associations with acute myelogenous leukemia.. 16. 1977
Cortisol metabolism in the perinatal period.. 10. 1976
Prognostic factors in metastatic germ cell tumors. 1990
The staging of M+ disease. 1990
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. 1996
Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy. 1994
Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection. 1994
Post cystectomy adjuvant chemotherapy: a clinical routine? 1992
Organ conservation and reconstruction in advanced bladder cancer. 1991
Biology of residual breast cancer after therapy: a kinetic interpretation. 1990
Chemotherapy for invasive bladder tumors. 1990
Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy. 1990
Pathology of bladder cancer: assessment of the primary lesion and response to therapy. 1990
The role of surgery in initial staging and follow up. 1990
Treatment of locoregional germ cell tumor. 1990
BCG therapy of superficial bladder tumors. 1989
The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. 1989
Advances in testicular cancer--role of chemotherapy. 1988
Immunotherapy with GD2 specific monoclonal antibodies. 1988
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy. 1988
The National Polyp Study: overview of program and preliminary report of patient and polyp characteristics. 1988
Ethnic differences in reactions to drugs and xenobiotics. Nutrition as an environmental influence on chemical metabolism in man. 1986
Experimental models of bladder cancer: a critical review. 1986
Chemotherapy-based multi-modality therapy of esophageal cancer. 1985
Current concepts of the pathogenesis of fibrosis: lessons from pulmonary fibrosis. 1984
Human bone marrow fibroblast colony-forming units (CFU-F). 1984
Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. 1984
Properties of myelofibrosis-derived fibroblasts. 1984
The genetic epidemiology of hypertension: a review of past studies and current results for 948 persons in 48 Utah pedigrees. 1984

VIVO Weill Cornell Medical College

Progress in clinical and biological research Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)